XBiotech to Begin Constructing New R&D Facility on its 48-acre Campus
PremiumPress ReleasesXBiotech to Begin Constructing New R&D Facility on its 48-acre Campus
9M ago
XBiotech announces Kivitz is now Lead Investigator, Study Chairman
Premium
The Fly
XBiotech announces Kivitz is now Lead Investigator, Study Chairman
10M ago
XBiotech announces enrollment completion of Phase I trial for Hutrukin
Premium
The Fly
XBiotech announces enrollment completion of Phase I trial for Hutrukin
12M ago
XBiotech Commences Tender Offer to Purchase up to $80,000,000 Worth of Its Shares
PremiumPress ReleasesXBiotech Commences Tender Offer to Purchase up to $80,000,000 Worth of Its Shares
1y ago
XBiotech announces first subject enrollment in Phase I trial for Hutrukin
Premium
The Fly
XBiotech announces first subject enrollment in Phase I trial for Hutrukin
1y ago
XBiotech Announces First Subject Enrollment in Phase I Clinical Trial for Hutrukin, a Novel Candidate Therapy for Stroke
Premium
Press Releases
XBiotech Announces First Subject Enrollment in Phase I Clinical Trial for Hutrukin, a Novel Candidate Therapy for Stroke
1y ago
XBiotech Announces First Patient Enrolled into the French National Cancer Institute (INCA) Sponsored Phase I/II/III Clinical Study for Natrunix™ Therapy for Colorectal Cancer
PremiumPress ReleasesXBiotech Announces First Patient Enrolled into the French National Cancer Institute (INCA) Sponsored Phase I/II/III Clinical Study for Natrunix™ Therapy for Colorectal Cancer
2y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100